BG Medicine, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by AFEYAN NOUBAR, was filed 01 Feb 2013.
BG Medicine, Inc.: what insiders have been doing
BG Medicine, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). BG Medicine, Inc. has had no insider filing for more than a year; the last one goes back to 4 May 2016.
Our records for BG Medicine, Inc. go back to 2011, with 24 purchases and 38 sales on the open market in total.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Since the insiders bought
- -45.3%Entry US$8.56 · Close at T+365 US$4.68
- -63.3%Entry US$6.20 · Close at T+365 US$2.28
- -54.8%Entry US$5.04 · Close at T+365 US$2.28
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
- 12,000 shares@ US$0.90Common StockSEC:0001209191-16-117514:0
- 15,493 shares@ US$0.36100.0% of flowCommon StockSEC:0001209191-16-112633:0
- 7,530 shares@ US$0.8365.9% of flowCommon StockSEC:0001209191-16-112629:0
- 6,233 shares@ US$0.8365.8% of flowCommon StockSEC:0001209191-16-112628:0
- 7,456 shares@ US$0.3634.2% of flowCommon StockSEC:0001209191-16-112630:0
- 8,986 shares@ US$0.3634.1% of flowCommon StockSEC:0001209191-16-112632:0
- 43,930 shares@ US$0.56Common StockSEC:0001209191-15-084684:0
- 2,508 shares@ US$0.56Common StockSEC:0001209191-15-084684:1
- 7,505 shares@ US$0.83Common StockSEC:0000899243-15-003612:0
- 6,233 shares@ US$0.83Common StockSEC:0000899243-15-003614:0
- 13,321 shares@ US$0.83Common StockSEC:0000899243-15-003610:0
- 3,390 shares@ US$2.27Common StockSEC:0001181431-15-008833:1
- 4,205 shares@ US$0.14Common StockSEC:0001181431-15-008833:2
- 265 shares@ US$2.27Common StockSEC:0001181431-15-008833:3
- 8,410 shares@ US$0.14Common StockSEC:0001181431-15-008833:10
- 530 shares@ US$2.27Common StockSEC:0001181431-15-008833:11
- 3,256 shares@ US$0.14Common StockSEC:0001181431-15-008835:0
- 206 shares@ US$2.27Common StockSEC:0001181431-15-008835:1
- 254 shares@ US$0.14Common StockSEC:0001181431-15-008835:2
- 16 shares@ US$2.27Common StockSEC:0001181431-15-008835:3
- 508 shares@ US$0.14Common StockSEC:0001181431-15-008835:10
- 32 shares@ US$2.27Common StockSEC:0001181431-15-008835:11
- 53,857 shares@ US$0.14Common StockSEC:0001181431-15-008833:0
- 6,301 shares@ US$0.36Common StockSEC:0001181431-14-038645:0
- 5,472 shares@ US$0.32Common StockSEC:0001181431-14-038645:1
25 of 143 declarations
About BG Medicine, Inc.
BG Medicine, Inc. is a company focused on developing diagnostic tests for metabolic diseases. It is listed on NASDAQ under the symbol BGMD.
